Taylor W F, Ivins J C, Dahlin D C, Edmonson J H, Pritchard D J
Mayo Clin Proc. 1978 Nov;53(11):695-700.
Survival of patients with primary osteosarcoma who received traditional surgical management has been very poor. Several studies have reported the percentage of patients alive 3 years after first treatment to be between 20 and 25%. In a study of such patients first treated at the Mayo Clinic between Jan. 1, 1963, and July 1, 1974, the survival noted in the first few years was typical of that of other reports, about 25%. However, by 1972 through mid-1974, the 3-year survival had become 50%. This improvement was not the result of adjuvant treatment or any basic change in type of patient treated, yet it is similar to that reported in connection with some of the new adjuvant therapies used in trials depending on historical controls. Our results cast doubt on findings made in the absence of concurrent, randomly selected controls.
接受传统手术治疗的原发性骨肉瘤患者的生存率一直很低。几项研究报告称,首次治疗后3年存活的患者比例在20%至25%之间。在一项对1963年1月1日至1974年7月1日在梅奥诊所首次接受治疗的此类患者的研究中,最初几年的生存率与其他报告的典型情况相似,约为25%。然而,到1972年至1974年年中,3年生存率已升至50%。这种改善并非辅助治疗的结果,也不是所治疗患者类型的任何根本性变化导致的,但它与一些依赖历史对照的试验中使用的新辅助疗法所报告的情况相似。我们的结果对在没有同期随机选择对照的情况下得出的研究结果提出了质疑。